Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's SyndromeSimon Bowman, Colin Everett, John O’Dwyer et al.|Arthritis & Rheumatology|2017Cited by 269
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trialAlexander C. Ford, Damien Hindmarch, Robbie Foy et al.|The Lancet|2023Cited by 138
Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudyBenjamin A. Fisher, Simon Bowman, Colin Everett et al.|Annals of the Rheumatic Diseases|2017Cited by 109